This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.